OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pharmaceutical Sciences is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Sustained release of RNA nanoparticles from reservoir implant for ocular delivery	191
Uptake Pathway of Styrene Maleic Acid Copolymer-Coated Lipid Emulsions Under Acidic Tumor Microenvironment	148
Metal-induced oxidation of polysorbate 80 in the presence of hydrogen peroxide: Mechanistic studies	119
An integrated approach combining experimental, informatics and energetic methods for solid form derisking of PF-06282999	87
Inline optical cell alignment inspection (IOCAI) improves data quality in sedimentation-velocity analytical ultracentrifugation experiments	83
A Modern Approach to Stability Studies via Bayesian Linear Mixed Models Incorporating Auxiliary Effects	77
Exploring a new approach in biopharmaceutics to improve the estimation of stomach solubilization from the mathematical model with a single stomach compartment setting: The impact of stomach solubiliza	68
Mechanistic insights into drug loading effect on dissolution performance of Loratadine–Soluplus® amorphous solid dispersions	66
Accelerated and Biopredictive In Vitro Release Testing Strategy for Single Agent and Combination Long-Acting Injectables	62
Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design	61
Insights into interactions between taxanes and P-glycoprotein using biophysical and in silico methods	60
Preparation and Characterization of Platelet Lysate (Pl)-Loaded Electrospun Nanofibers for Epidermal Wound Healing	59
PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model	56
Impact of dissolution medium pH and ionization state of the drug on the release performance of amorphous solid dispersions	55
Advanced Chemical and Imaging Methods for Studying Structure Morphology and Excipients Solid State Transformations in Pharmaceutical Multiparticulate Formulations	51
Docetaxel-dimer prodrug as a glutathione-responsive nano drug delivery system for improved chemotherapy	47
Physiologically-based pharmacokinetic modeling of rosuvastatin in Chinese: Predicting the impact of SLCO1B1 and ABCG2 genetic variants and hepatic impairment on drug exposure	47
3D printing of dose-flexible crystalline solid dispersion tablets suitable for preclinical and first-in-human studies	46
Noninvasive Moisture Detection in Lyophilized Drug Product Using NIR Spectrometer and Headspace Moisture Analyzer	46
Colloidal packing fraction in sedimented aluminum adjuvants dictate their resuspension rheology	46
Conformational Changes and Drivers of Monoclonal Antibody Liquid-Liquid Phase Separation	46
The Application of Virtual Therapeutic Drug Monitoring to Assess the Pharmacokinetics of Imatinib in a Chinese Cancer Population Group	44
Chitosan Nanoparticles Modified by Anredera cordifolia (Ten.) Steenis Leaf Extract for Enhancement of Azithromycin Encapsulation Efficiency and Loading Capacity: In vitro Drug Release Study	43
Effect of transcript length, temperature, and lyophilization on mRNA-lipid nanoparticle stability	43
The Enhanced Skin Permeation of Flavonoids Via the Application of a Coamorphous in a Microemulsion Formulation	40

Comment from Ailani et al on “Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques”	40
Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP)	40
Modeling and predicting tablet dissolution slowdown using an acceleration factor approach and constrained neural network	40
Development, Characterization and In Vitro Antimicrobial Evaluation of Novel Flavonoids Entrapped Micellar Topical Formulations of Neomycin Sulfate	39
Mannitol as an Excipient for Lyophilized Injectable Formulations	39
Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis	38
Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations	37
Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application	36
Development and characterization of low molecular weight heparin-triethanolamine cream: Skin permeability and antithrombotic efficacy	36
In Vitro Drug Release Testing Method For Nepafenac Ophthalmic Suspension	36